Literature DB >> 23901101

Structural basis for the stabilization of the complement alternative pathway C3 convertase by properdin.

Martín Alcorlo1, Agustín Tortajada, Santiago Rodríguez de Córdoba, Oscar Llorca.   

Abstract

Complement is an essential component of innate immunity. Its activation results in the assembly of unstable protease complexes, denominated C3/C5 convertases, leading to inflammation and lysis. Regulatory proteins inactivate C3/C5 convertases on host surfaces to avoid collateral tissue damage. On pathogen surfaces, properdin stabilizes C3/C5 convertases to efficiently fight infection. How properdin performs this function is, however, unclear. Using electron microscopy we show that the N- and C-terminal ends of adjacent monomers in properdin oligomers conform a curly vertex that holds together the AP convertase, interacting with both the C345C and vWA domains of C3b and Bb, respectively. Properdin also promotes a large displacement of the TED (thioester-containing domain) and CUB (complement protein subcomponents C1r/C1s, urchin embryonic growth factor and bone morphogenetic protein 1) domains of C3b, which likely impairs C3-convertase inactivation by regulatory proteins. The combined effect of molecular cross-linking and structural reorganization increases stability of the C3 convertase and facilitates recruitment of fluid-phase C3 convertase to the cell surfaces. Our model explains how properdin mediates the assembly of stabilized C3/C5-convertase clusters, which helps to localize complement amplification to pathogen surfaces.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23901101      PMCID: PMC3746899          DOI: 10.1073/pnas.1309618110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  The role of properdin in the assembly of the alternative pathway C3 convertases of complement.

Authors:  Dennis E Hourcade
Journal:  J Biol Chem       Date:  2005-11-21       Impact factor: 5.157

2.  Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.

Authors:  G N Fredrikson; J Westberg; E J Kuijper; C C Tijssen; A G Sjöholm; M Uhlén; L Truedsson
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

Review 3.  Interaction of complement with Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  P Densen
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

5.  A 34-amino acid peptide of the third component of complement mediates properdin binding.

Authors:  M E Daoudaki; J D Becherer; J D Lambris
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

6.  Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.

Authors:  T C Farries; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

7.  Analysis of the natural polymeric forms of human properdin and their functions in complement activation.

Authors:  M K Pangburn
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

8.  The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling.

Authors:  Zhe Sun; Kenneth B M Reid; Stephen J Perkins
Journal:  J Mol Biol       Date:  2004-11-05       Impact factor: 5.469

9.  Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis.

Authors:  Allison M Lesher; Lin Zhou; Yuko Kimura; Sayaka Sato; Damodar Gullipalli; Andrew P Herbert; Paul N Barlow; Hannes U Eberhardt; Christina Skerka; Peter F Zipfel; Takayuki Hamano; Takashi Miwa; Kenneth S Tung; Wen-Chao Song
Journal:  J Am Soc Nephrol       Date:  2012-11-30       Impact factor: 10.121

10.  Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function.

Authors:  J M Higgins; H Wiedemann; R Timpl; K B Reid
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

View more
  41 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  Anti-mouse properdin TSR 5/6 monoclonal antibodies block complement alternative pathway-dependent pathogenesis.

Authors:  Paula Bertram; Antonina M Akk; Hui-fang Zhou; Lynne M Mitchell; Christine T N Pham; Dennis E Hourcade
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2015-02

3.  Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.

Authors:  Serena Bettoni; Elena Bresin; Giuseppe Remuzzi; Marina Noris; Roberta Donadelli
Journal:  J Biol Chem       Date:  2016-02-22       Impact factor: 5.157

4.  Crystallization and X-ray analysis of monodisperse human properdin.

Authors:  Dennis Vestergaard Pedersen; Margot Revel; Trine Amalie Fogh Gadeberg; Gregers Rom Andersen
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-01-23       Impact factor: 1.056

Review 5.  How novel structures inform understanding of complement function.

Authors:  Elena Goicoechea de Jorge; Hugo Yebenes; Marina Serna; Agustín Tortajada; Oscar Llorca; Santiago Rodríguez de Córdoba
Journal:  Semin Immunopathol       Date:  2017-08-14       Impact factor: 9.623

6.  Functional and structural insight into properdin control of complement alternative pathway amplification.

Authors:  Dennis V Pedersen; Lubka Roumenina; Rasmus K Jensen; Trine Af Gadeberg; Chiara Marinozzi; Capucine Picard; Tania Rybkine; Steffen Thiel; Uffe Bs Sørensen; Cordula Stover; Veronique Fremeaux-Bacchi; Gregers R Andersen
Journal:  EMBO J       Date:  2017-03-06       Impact factor: 11.598

7.  Properdin binding to complement activating surfaces depends on initial C3b deposition.

Authors:  Morten Harboe; Christina Johnson; Stig Nymo; Karin Ekholt; Camilla Schjalm; Julie K Lindstad; Anne Pharo; Bernt Christian Hellerud; Kristina Nilsson Ekdahl; Tom Eirik Mollnes; Per H Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

8.  Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.

Authors:  Elisa Ramos-Sevillano; Ana Urzainqui; Susana Campuzano; Miriam Moscoso; Fernando González-Camacho; Mirian Domenech; Santiago Rodríguez de Córdoba; Francisco Sánchez-Madrid; Jeremy S Brown; Ernesto García; Jose Yuste
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

9.  Variability of Complement Response toward Preclinical and Clinical Nanocarriers in the General Population.

Authors:  Halli Benasutti; Guankui Wang; Vivian P Vu; Robert Scheinman; Ernest Groman; Laura Saba; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2017-11-01       Impact factor: 4.774

10.  Identification of peptidic inhibitors of the alternative complement pathway based on Staphylococcus aureus SCIN proteins.

Authors:  Brady J Summers; Brandon L Garcia; Jordan L Woehl; Kasra X Ramyar; Xiaolan Yao; Brian V Geisbrecht
Journal:  Mol Immunol       Date:  2015-06-04       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.